Global TMJ Disorders Market Research Report—Forecast till 2027

Global TMJ Disorders Market Research Report—Forecast till 2027

$4450 – $6250

Global TMJ Disorders Market was valued at USD 650.07 Million in 2019 and is expected to register a CAGR of 4.18 % during the forecast period of 2020 to 2027. T

SKU: MRFR210137 Category: Tags: , , , , , , , , ,

Description

Global TMJ Disorders Market Research Report—Forecast till 2027
Market Overview
Global TMJ Disorders Market was valued at USD 650.07 Million in 2019 and is expected to register a CAGR of 4.18 % during the forecast period of 2020 to 2027. Temporomandibular joint and muscle disorders are referred to as TMJ disorder that causes pain in the muscles and joints jaw. The increasing introduction and rapid adoption of advanced treatments and easy availability of medicines, rising prevalence of TMJ disorders, and increase in healthcare expenditure are expected to propel the market growth during the review period.

The global TMJ Disorder Market is expected to register a healthy market growth owing to the increase in technological advancement and increasing prevalence of these disorders. The emergence of non-surgical and surgical treatment methods for TMJ disorders is expected to drive market growth during the review period. TMJ disorders are the second-most commonly occurring musculoskeletal conditions resulting in pain and disability. The occurrences of TMD peaks from the age of 20-40 years, and it is found to be more prevalent in women than men. Additionally, women who use supplemental estrogenic or oral contraceptives are more expected to seek treatment for these conditions. Therefore, the increasing prevalence of these disorders in these populations is further fuelling the market growth during the review period.
Market Segmentation
The Global TMJ Disorders Market has been classified into Type, treatment, and end-user.
Based on type segment, the Global TMJ Disorders Market, based on Type classified into myofascial Pain, Internal Derangement (ID), and Osteoarthritis.
In terms of treatment, the market has been divided into medication, therapies, surgical, and others. The medication segment is further sub-divided into pain relievers, anti-inflammatories, tricyclic antidepressants, muscle relaxants, and others.
Based on end-user, the global TMJ disorders market is segmented into hospitals and clinics, ambulatory surgery centers, academic institutes, and others.
Regional Analysis
Geographically, the Global TMJ Disorder Market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas market has been divided into North America and Latin America, with the North America market further segmented into the US and Canada. The Americas is expected to dominate the global market owing to the largest share of 49.20% of the TMJ disorder market in 2019. This largest share is driven by the introduction and rapid adoption of advanced treatments in the region.
The European TMJ disorder market has been bifurcated into Western Europe and Eastern Europe. The Western Europe TMJ disorder market has further been divided into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The TMJ disorder market in Asia-Pacific has been classified into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The Middle East & Africa TMJ disorder market has been segmented into the Middle East and Africa.
Major Players
The key players in the global TMJ Disorders market are Abbott Laboratories, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Allergan, Bayer AG, Zydus Cadila, Mylan NV, Novartis International AG, and Jubilant Life Sciences Limited.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENT 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 15 2.2 RESEARCH OBJECTIVE 15 2.3 MARKET STRUCTURE 15 2.4 ASSUMPTIONS & LIMITATIONS 16 3 RESEARCH METHODOLOGY 3.1 DATA MINING 17 3.2 SECONDARY RESEARCH 18 3.3 PRIMARY RESEARCH 19 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 20 3.5 FORECASTING TECHNIQUES 20 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22 3.6.1 BOTTOM-UP APPROACH 23 3.6.2 TOP-DOWN APPROACH 23 3.7 DATA TRIANGULATION 24 3.8 VALIDATION 24 4 MARKET DYNAMICS 4.1 OVERVIEW 25 4.2 DRIVERS 26 4.2.1 GROWING RATES OF PET OWNERSHIP 26 4.2.2 RISING ZOONOTIC & CHRONIC DISEASES ANIMALS 26 4.2.3 INCREASING MEAT CONSUMPTION ATTRACTING MANDATORY VACCINATION 26 4.3 RESTRAINT 27 4.3.1 SHORTAGE OF VETERINARIANS 27 4.3.2 STRINGENT REGULATORY GUIDELINES PERTAINING TO VACCINES APPROVAL FOR ANIMALS 27 4.4 OPPORTUNITY 28 4.4.1 INCREASING INVESTMENT IN VETERINARY HOSPITALS 28 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 29 5.1.1 R&D 30 5.1.2 MANUFACTURING 30 5.1.3 DISTRIBUTION & SALES 30 5.1.4 POST-SALES REVIEW/MONITORING 30 5.2 PORTER'S FIVE FORCES MODEL 31 5.2.1 THREAT OF NEW ENTRANTS 31 5.2.2 BARGAINING POWER OF SUPPLIERS 32 5.2.3 THREAT OF SUBSTITUTES 32 5.2.4 BARGAINING POWER OF BUYERS 32 5.2.5 INTENSITY OF RIVALRY 32 5.3 IMPACT OF COVID-19 32 5.3.1 OVERVIEW 32 5.3.2 IMPACT ON MEAT CONSUMPTION 33 5.3.3 IMPACT ON VETERINARY MEDICINE MARKET 33 6 GLOBAL VETERINARY MEDICINE MARKET, BY ANIMAL TYPE 6.1 OVERVIEW 34 6.2 DOMESTICATED 35 6.3 COMPANION 35 7 GLOBAL VETERINARY MEDICINE MARKET, BY PRODUCT 7.1 OVERVIEW 37 7.2 DRUG 38 7.3 VACCINES 39 8 GLOBAL VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION 8.1 OVERVIEW 40 8.2 ORAL 41 8.3 PARENTERAL 41 8.4 OTHERS 42 9 GLOBAL VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL 9.1 OVERVIEW 43 9.2 VETERINARY HOSPITALS & CLINICS 44 9.3 RETAIL STORES 44 9.4 ONLINE PHARMACIES 45 10 GLOBAL VETERINARY MEDICINE MARKET, BY REGION 10.1 OVERVIEW 46 10.2 AMERICAS 48 10.2.1 NORTH AMERICA 50 10.2.1.1 US 52 10.2.1.2 CANADA 53 10.2.2 LATIN AMERICA 54 10.3 EUROPE 56 10.3.1 WESTERN EUROPE 58 10.3.1.1 GERMANY 60 10.3.1.2 UK 61 10.3.1.3 FRANCE 62 10.3.1.4 ITALY 63 10.3.1.5 SPAIN 64 10.3.1.6 REST OF WESTERN EUROPE 65 10.3.2 EASTERN EUROPE 67 10.4 ASIA-PACIFIC 69 10.4.1 CHINA 71 10.4.2 JAPAN 72 10.4.3 INDIA 73 10.4.4 AUSTRALIA 74 10.4.5 SOUTH KOREA 75 10.4.6 REST OF ASIA-PACIFIC 76 10.5 MIDDLE EAST & AFRICA 78 10.5.1 SAUDI ARABIA 80 10.5.2 UNITED ARAB EMIRATES 81 10.5.3 OMAN 83 10.5.4 KUWAIT 84 10.5.5 QATAR 85 10.5.6 REST OF THE MIDDLE EAST & AFRICA 86 11 COMPETITIVE LANDSCAPE 11.1 OVERVIEW 88 11.2 COMPETITIVE BENCHMARKING 89 11.3 GLOBAL VETERINARY MEDICINE MARKET: COMPANY RANKING 90 11.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 91 11.5 MAJOR GROWTH STRATEGY IN THE GLOBAL VETERINARY MEDICINE MARKET 91 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 92 11.6.1 NEW PRODUCT LAUNCHES 92 11.6.2 PARTNERSHIPS/AGREEMENTS 92 11.6.3 EXPANSIONS 93 11.6.4 ACQUISITIONS 93 11.7 FINANCIAL MATRIX 94 12 COMPANY PROFILES 12.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 96 12.1.1 COMPANY OVERVIEW 96 12.1.2 FINANCIAL OVERVIEW 97 12.1.3 PRODUCTS/SERVICES OFFERED 97 12.1.4 KEY DEVELOPMENTS 99 12.1.5 SWOT ANALYSIS 99 12.1.6 KEY STRATEGIES 100 12.2 CEVA 101 12.2.1 COMPANY OVERVIEW 101 12.2.2 FINANCIAL OVERVIEW 101 12.2.3 PRODUCTS/SERVICES OFFERED 102 12.2.4 KEY DEVELOPMENTS 102 12.2.5 SWOT ANALYSIS 103 12.2.6 KEY STRATEGIES 103 12.3 ZOETIS 104 12.3.1 COMPANY OVERVIEW 104 12.3.2 FINANCIAL OVERVIEW 104 12.3.3 PRODUCTS/SERVICES OFFERED 105 12.3.4 KEY DEVELOPMENTS 107 12.3.5 SWOT ANALYSIS 107 12.3.6 KEY STRATEGIES 107 12.4 MERCK ANIMAL HEALTH 108 12.4.1 COMPANY OVERVIEW 108 12.4.2 FINANCIAL OVERVIEW 109 12.4.3 PRODUCTS/SERVICES OFFERED 110 12.4.4 KEY DEVELOPMENTS 111 12.4.5 SWOT ANALYSIS 112 12.4.6 KEY STRATEGIES 112 12.5 CHANELLE PHARMA GROUP 113 12.5.1 COMPANY OVERVIEW 113 12.5.2 FINANCIAL OVERVIEW 113 12.5.3 PRODUCTS/SERVICES OFFERED 113 12.5.4 KEY DEVELOPMENTS 115 12.5.5 SWOT ANALYSIS 115 12.5.6 KEY STRATEGIES 115 12.6 ELANCO 116 12.6.1 COMPANY OVERVIEW 116 12.6.2 FINANCIAL OVERVIEW 117 12.6.3 PRODUCTS/SERVICES OFFERED 118 12.6.4 KEY DEVELOPMENTS 119 12.6.5 SWOT ANALYSIS 120 12.6.6 KEY STRATEGIES 120 12.7 DECHRA PHARMACEUTICALS PLC 121 12.7.1 COMPANY OVERVIEW 121 12.7.2 FINANCIAL OVERVIEW 121 12.7.3 PRODUCTS/SERVICES OFFERED 122 12.7.4 KEY DEVELOPMENTS 123 12.7.5 SWOT ANALYSIS 123 12.7.6 KEY STRATEGIES 123 12.8 BAYER AG 124 12.8.1 COMPANY OVERVIEW 124 12.8.2 FINANCIAL OVERVIEW 124 12.8.3 PRODUCTS/SERVICES OFFERED 125 12.8.4 KEY DEVELOPMENTS 126 12.8.5 SWOT ANALYSIS 127 12.8.6 KEY STRATEGIES 127 12.9 VETOQUINOL SA. 128 12.9.1 COMPANY OVERVIEW 128 12.9.2 FINANCIAL OVERVIEW 128 12.9.3 PRODUCTS/SERVICES OFFERED 129 12.9.4 KEY DEVELOPMENTS 131 12.9.5 SWOT ANALYSIS 132 12.9.6 KEY STRATEGIES 132 12.10 NORBROOK LABORATORIES 133 12.10.1 COMPANY OVERVIEW 133 12.10.2 FINANCIAL OVERVIEW 133 12.10.3 PRODUCTS/SERVICES OFFERED 133 12.10.4 KEY DEVELOPMENTS 135 12.10.5 SWOT ANALYSIS 135 12.10.6 KEY STRATEGIES 136 13 APPENDIX 13.1 REFERENCES 137 13.2 RELATED REPORTS 138

Reviews

There are no reviews yet.

Be the first to review “Global TMJ Disorders Market Research Report—Forecast till 2027”

Related products